News & Articles
Go-to-Market Success in Biologics: Lessons Learned from Global Launches
Biologics have transformed healthcare over the last two decades, offering highly targeted treatments for oncology, autoimmune, and rare diseases. But bringing a biologic from lab to market is rarely straightforward—especially...
Read MoreFrom Pricing to Patient Access: Strategies That Work for Advanced Therapies in LMICs
Advanced therapies such as cell and gene therapy (CGT) and biologics are reshaping healthcare by offering transformative outcomes for complex diseases. Yet in low- and middle-income countries (LMICs), where healthcare...
Read MoreBreaking Barriers: Accelerating Cell & Gene Therapy Access in Emerging Markets
Cell and Gene Therapy (CGT) has transformed the landscape of modern medicine, offering curative potential for diseases once considered untreatable. However, despite these groundbreaking innovations, access to CGT remains limited—particularly...
Read More